Dark Mode
More forecasts: Johannesburg 14 days weather
  • Monday, 23 December 2024
Ryan Garcia Denies Steroid Use Amidst Failed Drug Test Reports

Ryan Garcia Denies Steroid Use Amidst Failed Drug Test Reports

Allegations of Failed Tests

Reports surfaced on Wednesday regarding boxer Ryan Garcia's alleged failed drug tests before and after his fight against Devin Haney in April. The tests, conducted by the Voluntary Anti-Doping Association (Vada), reportedly revealed the presence of the banned substance Ostarine.

 

Garcia's Response

Denying the allegations, Garcia, 25, vehemently denied using steroids, stating that he has never taken any and doesn't even know where to acquire them. He emphasized his clean record and questioned the motive behind the accusations, particularly highlighting his willingness to undergo drug testing voluntarily.

 

Controversy Surrounding Victory

Garcia's majority-decision victory over Haney, during which he dropped Haney three times, was considered a significant upset. However, the victory was overshadowed by concerns regarding Garcia's behavior leading up to the fight, including a mental-health evaluation and missing weight by three pounds.

 

Promoter's Support

Golden Boy Promotions, Garcia's promoter, stood by him, stating their belief in his innocence and affirming that Garcia has consistently denied knowingly using banned substances. They also expressed their intent to investigate the circumstances surrounding the failed drug tests.

 

Impact on Title Bout

Garcia's failed weigh-in rendered him ineligible to win the WBC super-lightweight title, which Haney was defending. Despite Haney's undefeated status before the fight, Garcia's victory was marred by controversy, particularly with lingering questions about the integrity of the competition.

 

Context of Professional Journey

Garcia's defeat against Gervonta Davis in his previous professional bout adds context to the situation, highlighting the importance of maintaining a clean record amidst the competitive world of boxing.

 

Comment / Reply From